Results (continued) Diagnosis of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis, pancreatic cancer and gastrointestinal or pancreatic surgery patients: a systematic literature review and expert consensus on the accuracy of diagnostic tests used in Spain.
De-Madaria E 1 , González -Carro P 2 , Boadas Mir J 3 , Puig de la Bellacasa J 4 The literature search, including expert feedback on the search strategy, gave a total of 13,376 publications on the diagnostic accuracy of PEI tests were initially identified. Of these, 16 were selected. Three additional publications were identified by handsearch (references from other publications) and reviewed ( Figure 2 ).
After presenting the results to 4 experts, the papers related to Endoscopic Ultrasound (EUS), initially included as a diagnostic technique were excluded. The accuracy review finally included 14 papers from the systematic search and 3 from hand-search that:
• Contained information distributed per population and test as reported in Figure 3 . The most studied population and test are CP and FE-I, respectively.
• Used different reference standards as represented in Figure 4 . Most of the publications used a type of secretin/cerulein test as reference standard for measuring test accuracy.
• Reported sensitivity and specificity values (assessed vs. different reference standards) that spanned wide ranges, when many publications were available per test and population, as represented in Table 1 . FE-I is the test spanning the widest ranges of specificity and sensitivity values, in both populations of interest.
When presented the accuracy data extracted from the literature, the experts advised:
• Not to consider publications using the secretin/cerulein test as the reference standard for accuracy of PEI diagnosis, because this test only measures pancreatic enzyme secretion, not exocrine insufficiency per se;
• To prioritize studies using the gold standard CFA (assumed accuracy 100%) or 13C-MTG test as reference standard for accuracy.
On the basis of these considerations:
• 4 publications using CFA as the reference standard were selected: FE-I sensitivity and specificity in 58 CP (cutoff <218μg/g; [1] ) and 40 cancer/surgery patients (cutoff 200μg/g; [2] ) were 68% and 98%, and 91% and 35%, respectively; 13C-MTG was ≥90% sensitive and specific in all populations [3, 4] .
• Sensitivity and specificity for SNM vs. MTG were 80% and 81%, respectively [5] and considered by experts as similarly accurate in the cancer/surgery population.
The extracted specificity and sensitivity values of the four tests in CP patients and cancer/surgery patients are reported in Figure 5 and Figure 6 , respectively. Figure 2 . Selection process for test accuracy publications of the systematic review 1 Hospital General Universitario de Alicante, Alicante (Spain), 2 Complejo Hospitalario La Mancha-Centro, Alcázar de San Juan, Ciudad Real (Spain), 3 Consorci Sanitari de Terrassa, Terrassa (Spain), 4 Abbott Laboratories, Madrid (Spain), 5 Abbott Laboratories, Basel (Switzerland), 6 Outcomes'10, Castellón (Spain), 7 Agency for Health Economic Assessment and Dissemination, Loerrach (Germany), 8 Hospital Universitario de Santiago de Compostela, Santiago de Compostela (Spain 
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